Works matching IS 14783223 AND DT 2021 AND VI 41 AND IP 5

Results: 41

Hepatobiliary contrast agents in MR: Where we stand and future perspectives.

Published in:

Liver International, 2021, v. 41, n. 5, p. 888, doi. 10.1111/liv.14883

By:

Rimola, Jordi;
Forner, Alejandro

Publication type:

Article

Post hepatitis B‐eliminated hepatocellular carcinoma: New challenges.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1173, doi. 10.1111/liv.14878

By:

Huo, Teh‐Ia;
Ho, Shu‐Yein;
Tsai, Ping‐Hsing

Publication type:

Article

Understanding surrogate measures of overall survival after trans‐arterial chemoembolization of hepatocellular carcinoma.

Published in:

Liver International, 2021, v. 41, n. 5, p. 891, doi. 10.1111/liv.14873

By:

Cucchetti, Alessandro;
Casadei Gardini, Andrea

Publication type:

Article

HCV cirrhotic patients treated with direct‐acting antivirals: Detection of tubular dysfunction and resolution after viral clearance.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1171, doi. 10.1111/liv.14861

By:

Danjuma, Mohammed Ibn‐Mas'ud;
AbouJabal, Bodoor;
Naseralallah, Lina Mohammad Ahmad;
Elzouki, Abdelnaser

Publication type:

Article

Corrigendum.

Published in:: Liver International, 2021, v. 41, n. 5, p. 1175, doi. 10.1111/liv.14859
Publication type:: Article

Diagnostic performance of MRI using extracellular contrast agents versus gadoxetic acid for hepatocellular carcinoma: A systematic review and meta‐analysis.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1117, doi. 10.1111/liv.14850

By:

Feng, Zhichao;
Zhao, Huafei;
Guan, Shiwei;
Wang, Wei;
Rong, Pengfei

Publication type:

Article

Epidemiological projections of viral‐induced hepatocellular carcinoma in the perspective of WHO global hepatitis elimination.

Published in:

Liver International, 2021, v. 41, n. 5, p. 915, doi. 10.1111/liv.14843

By:

Vo Quang, Erwan;
Shimakawa, Yusuke;
Nahon, Pierre

Publication type:

Article

Exome sequencing in patient‐parent trios suggests new candidate genes for early‐onset primary sclerosing cholangitis.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1044, doi. 10.1111/liv.14831

By:

Haisma, Sjoukje‐Marije;
Weersma, Rinse K.;
Joosse, Maria E.;
Koning, Barbara A. E.;
Meij, Tim;
Koot, Bart G. P.;
Wolters, Victorien;
Norbruis, Obbe;
Daly, Mark J.;
Stevens, Christine;
Xavier, Ramnik J.;
Koskela, Jukka;
Rivas, Manuel A.;
Visschedijk, Marijn C.;
Verkade, Henkjan J.;
Barbieri, Ruggero;
Jansen, Dianne B. H.;
Festen, Eleonora A. M.;
Rheenen, Patrick F.;
Diemen, Cleo C.

Publication type:

Article

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry.

Published in:

Liver International, 2021, v. 41, n. 5, p. 949, doi. 10.1111/liv.14829

By:

Wedemeyer, Heiner;
Erren, Peter;
Naumann, Uwe;
Rieke, Ansgar;
Stoehr, Albrecht;
Zimmermann, Tim;
Lohmann, Kristina;
König, Bettina;
Mauss, Stefan

Publication type:

Article

Cirrhotic cardiomyopathy prevalence according to the new criteria.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1170, doi. 10.1111/liv.14826

By:

Izzy, Manhal;
Lin, Grace;
Watt, Kymberly D.

Publication type:

Article

Fibroblast Growth Factor 19: Potential modulation of hepatic metabolism for the treatment of non‐alcoholic fatty liver disease.

Published in:

Liver International, 2021, v. 41, n. 5, p. 894, doi. 10.1111/liv.14802

By:

Sciarrillo, Christina M.;
Keirns, Bryant H.;
Koemel, Nicholas A.;
Anderson, Kendall L.;
Emerson, Sam R.

Publication type:

Article

Atezolizumab and bevacizumab combination compared with sorafenib as the first‐line systemic treatment for patients with unresectable hepatocellular carcinoma: A cost‐effectiveness analysis in China and the United states.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1097, doi. 10.1111/liv.14795

By:

Wen, Feng;
Zheng, Hanrui;
Zhang, Pengfei;
Liao, Weiting;
Zhou, Kexun;
Li, Qiu

Publication type:

Article

HCV microelimination strategies: An interventional study in diagnosed patients without access to the system.

Published in:

Liver International, 2021, v. 41, n. 5, p. 928, doi. 10.1111/liv.14824

By:

Guerra Veloz, María Fernanda;
Del Pino Bellido, Pilar;
Cordero Ruiz, Patricia;
Vega Rodriguez, Francisco;
Bellido Muñoz, Francisco;
Ramirez de Arellano, Encarnación;
Caunedo Álvarez, Angel;
Pascual Hernandez, Alvaro;
Carmona Soria, Isabel

Publication type:

Article

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries.

Published in:

Liver International, 2021, v. 41, n. 5, p. 934, doi. 10.1111/liv.14808

By:

Mennini, Francesco S.;
Marcellusi, Andrea;
Robbins Scott, Sarah;
Montilla, Simona;
Craxi, Antonio;
Buti, Maria;
Gheorghe, Liana;
Ryder, Stephen;
Kondili, Loreta A.

Publication type:

Article

Therapeutic plasma‐exchange improves systemic inflammation and survival in acute‐on‐chronic liver failure: A propensity‐score matched study from AARC.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1083, doi. 10.1111/liv.14806

By:

Maiwall, Rakhi;
Bajpai, Meenu;
Choudhury, Ashok K.;
Kumar, Anupam;
Sharma, Manoj Kumar;
Duan, Zhongping;
Yu, Chen;
Hu, Jinhua;
Ghazinian, Hasmik;
Ning, Qin;
Ma, Ke;
Lee, Guan H.;
Lim, Seng G.;
Shah, Samir;
Kalal, Chetan;
Dokmeci, Abdulkadir;
Kumar, Guresh;
Jain, Priyanka;
Rao Pasupuleti, Samba Siva;
Paulson, Irene

Publication type:

Article

Bariatric surgery and the risk of alcohol‐related cirrhosis and alcohol misuse.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1012, doi. 10.1111/liv.14805

By:

Mellinger, Jessica L.;
Shedden, Kerby;
Winder, G. Scott;
Fernandez, Anne C.;
Lee, Brian P.;
Waljee, Jennifer;
Fontana, Robert;
Volk, Michael L.;
Blow, Frederic C.;
Lok, Anna S. F.

Publication type:

Article

Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization?

Published in:

Liver International, 2021, v. 41, n. 5, p. 1105, doi. 10.1111/liv.14822

By:

Celsa, Ciro;
Cabibbo, Giuseppe;
Enea, Marco;
Battaglia, Salvatore;
Rizzo, Giacomo E. M.;
Busacca, Anita;
Giuffrida, Paolo;
Stornello, Caterina;
Brancatelli, Giuseppe;
Cannella, Roberto;
Gruttadauria, Salvatore;
Cammà, Calogero

Publication type:

Article

Genetically engineered E. coli Nissle attenuates hyperammonemia and prevents memory impairment in bile‐duct ligated rats.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1020, doi. 10.1111/liv.14815

By:

Ochoa‐Sanchez, Rafael;
Oliveira, Mariana M.;
Tremblay, Mélanie;
Petrazzo, Grégory;
Pant, Asha;
Bosoi, Cristina R.;
Perreault, Mylene;
Querbes, William;
Kurtz, Caroline B.;
Rose, Christopher F.

Publication type:

Article

Chanarin‐Dorfman Syndrome: A comprehensive review.

Published in:

Liver International, 2021, v. 41, n. 5, p. 905, doi. 10.1111/liv.14794

By:

Cakmak, Erol;
Bagci, Gokhan

Publication type:

Article

Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE).

Published in:

Liver International, 2021, v. 41, n. 5, p. 1070, doi. 10.1111/liv.14785

By:

Formentin, Chiara;
Zarantonello, Lisa;
Mangini, Chiara;
Frigo, Anna C.;
Montagnese, Sara;
Merkel, Carlo

Publication type:

Article

Expansion of dysfunctional CD56‐CD16+ NK cells in chronic hepatitis B patients.

Published in:

Liver International, 2021, v. 41, n. 5, p. 969, doi. 10.1111/liv.14784

By:

Wijaya, Ratna S.;
Read, Scott A.;
Schibeci, Stephen;
Han, Shuanglin;
Azardaryany, Mahmoud K.;
Poorten, David;
Lin, Rita;
Yuen, Lawrence;
Lam, Vincent;
Douglas, Mark W.;
George, Jacob;
Ahlenstiel, Golo

Publication type:

Article

Tribbles homolog 2 promotes hepatic fibrosis and hepatocarcinogenesis through phosphatase 1A‐Mediated stabilization of yes‐associated protein.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1131, doi. 10.1111/liv.14782

By:

Xiang, Dejuan;
Zhu, Xiaoyun;
Zhang, Yanqiu;
Zou, Jie;
Li, Jie;
Kong, Lingyi;
Zhang, Hao

Publication type:

Article

A potential impact of Helicobacter pylori‐related sarcopenia on severity of portal hypertension.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1168, doi. 10.1111/liv.14777

By:

Kountouras, Jannis;
Papaefthymiou, Apostolis;
Polyzos, Stergios A;
Doulberis, Michael

Publication type:

Article

Glycogenosis is common in nonalcoholic fatty liver disease and is independently associated with ballooning, but lower steatosis and lower fibrosis.

Published in:

Liver International, 2021, v. 41, n. 5, p. 996, doi. 10.1111/liv.14773

By:

Allende, Daniela S;
Gawrieh, Samer;
Cummings, Oscar W;
Belt, Patricia;
Wilson, Laura;
Van Natta, Mark;
Behling, Cynthia A;
Carpenter, Danielle;
Gill, Ryan M;
Kleiner, David E;
Yeh, Mathew M;
Chalasani, Naga;
Guy, Cynthia D

Publication type:

Article

Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence.

Published in:

Liver International, 2021, v. 41, n. 5, p. 956, doi. 10.1111/liv.14772

By:

Wang, Shu‐Chi;
Li, Chia‐Yang;
Chang, Wen‐Tsan;
Cheng, Wei‐Chung;
Yen, Chia‐Hung;
Tu, Wen‐Yu;
Lin, Zu‐Yau;
Lin, Ching‐Chih;
Yeh, Ming‐Lun;
Huang, Chung‐Feng;
Huang, Jee‐Fu;
Dai, Chia‐Yen;
Chuang, Wan‐Long;
Chen, Yao‐Li;
Yu, Ming‐Lung

Publication type:

Article

Co‐expression of IL‐7 and PH20 promote anti‐GPC3 CAR‐T tumour suppressor activity in vivo and in vitro.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1033, doi. 10.1111/liv.14771

By:

Xiong, Xingcheng;
Xi, Juanli;
Liu, Qian;
Wang, Cixiao;
Jiang, Zeyou;
Yue, Su‐Yang;
Shi, Lei;
Rong, Yuping;
Berasain, Carmen

Publication type:

Article

The dual role of non‐selective beta‐blockers in cirrhotic patients: How do we know when Dr Jekyll turns into Mr Hyde?

Published in:

Liver International, 2021, v. 41, n. 5, p. 1166, doi. 10.1111/liv.14770

By:

Thevenot, Thierry;
Mouhat, Basile;
Cervoni, Jean‐Paul;
Chopard, Romain

Publication type:

Article

The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1058, doi. 10.1111/liv.14769

By:

Razpotnik, Marcel;
Bota, Simona;
Wimmer, Philipp;
Hackl, Michael;
Lesnik, Gerald;
Alber, Hannes;
Peck‐Radosavljevic, Markus;
Hernandez‐Gea, Virginia

Publication type:

Article

Isolated liver tuberculoma infiltrating anterior abdominal wall and skin.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1129, doi. 10.1111/liv.14764

By:

Romic, Ivan;
Pavlek, Goran;
Romic, Marijan;
Romic, Renata;
Forner, Alejando

Publication type:

Article

Microalbuminuria in NAFLD patients: The impact of cardiovascular system.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1164, doi. 10.1111/liv.14751

By:

Cholongitas, Evangelos;
Tsilingiris, Dimitrios;
Papatheodoridis, George V.;
Tentolouris, Nikolaos;
Valenti, Luca

Publication type:

Article

Re: Fouad Y, et al. The NAFLD‐MAFLD debate: Eminence versus evidence. Liver Int. 2020 Nov 21. doi: 10.1111/liv.14739.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1162, doi. 10.1111/liv.14750

By:

Sierra, Fernando;
Cárdenas, Andrés

Publication type:

Article

Fibrosis progression rate in a systematic review of placebo‐treated nonalcoholic steatohepatitis.

Published in:

Liver International, 2021, v. 41, n. 5, p. 982, doi. 10.1111/liv.14749

By:

Roskilly, Anna;
Hicks, Amy;
Taylor, Eleanor J.;
Jones, Rebecca;
Parker, Richard;
Rowe, Ian A.

Publication type:

Article

Non‐invasive diagnosis methods are needed in paediatric non‐alcoholic fatty liver disease.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1161, doi. 10.1111/liv.14748

By:

Li, Jie;
Nguyen, Mindie H.

Publication type:

Article

Low skeletal muscle mass and significant fibrosis in non‐alcoholic fatty liver disease: Cause or effect?

Published in:

Liver International, 2021, v. 41, n. 5, p. 1160, doi. 10.1111/liv.14746

By:

Anand, Abhinav;
Sharma, Sanchit;
Saraya, Anoop

Publication type:

Article

Genetic insight into COVID‐19 related liver injury: A note on MBOAT7.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1157, doi. 10.1111/liv.14732

By:

Machill, Antonia;
Bals, Robert;
Lammert, Frank;
Krawczyk, Marcin

Publication type:

Article

Reply to: Suboptimal accuracy of GES score to stratify post SVR HCC risk in a single‐centre cohort of European cirrhotics.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1155, doi. 10.1111/liv.14724

By:

Shiha, Gamal;
Soliman, Reham;
Mikhail, Nabiel;
Eslam, Mohammed

Publication type:

Article

Some concerns about "PDCD1 and IFNL4 genetic variants and risk of developing hepatitis C virus‐related diseases".

Published in:

Liver International, 2021, v. 41, n. 5, p. 1154, doi. 10.1111/liv.14702

By:

Liu, Yanqing

Publication type:

Article

Suboptimal accuracy of GES score to stratify post‐SVR HCC risk in a single center cohort of European cirrhotics infected with any HCV genotype.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1152, doi. 10.1111/liv.14700

By:

Bergna, Irene;
Degasperi, Elisabetta;
D'Ambrosio, Roberta

Publication type:

Article

Diagnostic accuracy of simple laboratory tests is not replicable in paediatric fulminant Wilson's disease.

Published in:

Liver International, 2021, v. 41, n. 5, p. 1150, doi. 10.1111/liv.14678

By:

Kim, Yu Bin;
Oh, Seak Hee;
Ko, Jae Sung;
Kim, Kyung Mo

Publication type:

Article

Predicting microvascular invasion in HCC with ctDNA: What are the pitfalls?

Published in:

Liver International, 2021, v. 41, n. 5, p. 1148, doi. 10.1111/liv.14536

By:

Huo, Teh‐Ia;
Ho, Shu‐Yein;
Liu, Po‐Hong

Publication type:

Article

Issue Information.

Published in:: Liver International, 2021, v. 41, n. 5, p. 883, doi. 10.1111/liv.14524
Publication type:: Article